Evaxion Biotech
Evaxion: EVX-03 Gets a New Indication (Redeye)
2022-06-24 10:00
Redeye is encouraged by the news from Evaxion concerning good pre-clinical results of EVX-03 and the decision to test it in a phase I/IIa trial in lung cancer.
info@redeye.se (Redeye.se)
Redeye AB - Redeye.se